NCT03127514 AMX0035 in Patients With Amyotrophic Lateral Sclerosis (ALS) Status COMPLETED Phase PHASE2
NCT03127267 Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients Status RECRUITING Phase PHASE3
NCT03095989 An Online Mindfulness Intervention for People With ALS and Their Caregivers Status COMPLETED Phase NA
NCT03095729 Cognitive Consequences of an Activation of the Cortical Drive to Breath (VENTIPSY) Status COMPLETED Phase N/A
NCT03090932 Longitudinal Study of Innate Lymphoid Cells in Peripheral Blood in ALS Status TERMINATED Phase N/A
NCT03085706 Transplantation of Autologous Peripheral Blood Mononuclear Cells for Amyotrophic Lateral Sclerosis Status COMPLETED Phase NA
NCT03068754 Study of Acthar® Gel (Acthar) for Amyotrophic Lateral Sclerosis (ALS) Status TERMINATED Phase PHASE2/PHASE3
NCT03067857 Autologous Bone Marrow-Derived Stem Cell Therapy for Motor Neuron Disease Status UNKNOWN Phase PHASE1/PHASE2
NCT03049046 CC100: Phase 1 Multiple-Dose Safety and Tolerability in Subjects With ALS Status UNKNOWN Phase PHASE1
NCT03034317 NeuRx Diaphram Pacing System (DPS) Use in Amyotrophic Lateral Sclerosis (ALS) Status WITHDRAWN Phase NA
NCT03020797 A Clinical Trial to Evaluate the Safety and Efficacy of Fycompa in Subjects With Amyotrophic Lateral Sclerosis (ALS) Status TERMINATED Phase NA